Notice

We use cookies to constantly improve our internet content and to create internal assessments pursuant to our data protection guidelines.

Further Information

OK

LINC Asia-Pacific 2014 Programme

Find all topics and speakers listed below.

Conference day 1

  • - , Main Auditorium

    Opening session – Ten years of innovation: The evolution of endovascular techniques – Current status, pioneering techniques and challenges ahead.

    Chairmen:
    Dierk Scheinert, Kiang Hiong Tay
    Moderators:
    Jun-Won Lee, Jiwei Zhang, Bryan Yan
    1. -

      Live case transmission from Taipei

    2. -

      Current concepts in CLI treatment

    3. -

      BTK management strategies and devices selection

        Kiang Hiong Tay
    4. -

      The role of drug-eluting devices in BTK interventions – latest insights

        Thomas Zeller
    5. -

      Outcome predictors in CLI interventions – Insights from clinical trials

        Ryoji Koshida
    6. -

      The role and technique of pedal arch angioplasty

        Tatsuya Nakama
    7. -

      Future concepts for femoro-popliteal and infrapopliteal interventions

    8. -

      Key considerations of SFA lesions Management

        Wei Liang
    9. -

      DEB vs. Stent vs. DES: When to use which technology

        Thomas Zeller
    10. -

      Live case transmission from Singapore, Changi General Hospital

    11. -

      Zilver® PTX® post-market surveillance study of paclitaxel-eluting stents for treating femoropopliteal artery disease in Japan: 12-month results

        Hiroyoshi Yokoi
    12. -

      The role of biomimetic stent technology for complex femoro-popliteal lesions

        Yiu-Che Chan
    13. -

      Atherectomy + DEB: A viable concept for the future?

        Giancarlo Biamino
    14. -

      Bioabsorbable scaffolds for peripheral arteries: How to make it work?

        Dierk Scheinert
    15. -

      Live case transmission from Taipei

  • - , Main Auditorium

    Symposium: Lutonix® drug coated balloons – clinical evidence & real world applications

    Chairman:
    Thomas Zeller
    Moderators:
    Michael Lichtenberg, Dierk Scheinert
    1. -

      Introduction by the chairman

    2. -

      A discussion of LEVANT II study design and 6 month data

        Dierk Scheinert
    3. -

      Single center experience global SFA registry

        Michael Lichtenberg
    4. -

      Live case transmission from Singapore, Changi General Hospital

    5. -

      Discussion and conclusion

  • - , Main Auditorium

    Lunch

  • - , Main Auditorium

    Tibiopedal access: Why not the first choice?

    Chairman:
    Thomas Zeller
    Moderators:
    Jackie Ho, Hsuan Li Huang, Lixin Wang
    1. -

      Tibiopedal access registry

        Thomas Zeller
    2. -

      Retrograde approach to crossing CTOs

        Donghoon Choi
    3. -

      Live case transmission from Singapore, Changi General Hospital

    4. -

      Transpedal artery access for tibiopedal lesions

        Osamu Iida
    5. -

      Retrograde intervention for CLI

        Bryan Yan
    6. -

      Live case transmission from Palermo

    7. -

      Discussion and conclusion

  • - , Main Auditorium

    Rationale and value of DEB therapy for femoropopliteal disease

    Chairman:
    Dierk Scheinert
    Moderators:
    Zhong Chen, Weiguo Fu, Osamu Iida, Ramon Varcoe
    1. -

      IN.PACT DEB Technology and pre-clinical evidence

        Christopher Owens
    2. -

      Live case transmission from Taipei

    3. -

      DEB and optimal PTA: why, when and how to use DEB

        Fabrizio Fanelli
    4. -

      IN.PACT DEB evidence: 2-year results from PACIFIER randomized trial

        Thomas Albrecht
    5. -

      Live case transmission from Palermo

    6. -

      Rationale and cost-effectiveness evidence of DEB

        Thomas Zeller
  • - , Main Auditorium

    Stent, drug or both. What’s the best way to treat the lower limb?

    Chairman:
    Sundeep Punamiya
    Moderators:
    Jackie Ho, Thomas Zeller, Jiwei Zhang
    1. -

      Introduction

    2. -

      Passeo-18 Lux DRB – the story so far: BIOLUX study results

        Dierk Scheinert
    3. -

      Live case transmission from Singapore, Changi General Hospital

    4. -

      Low profile stents in the SFA: Are they a workhorse option?

        Kiang Hiong Tay
    5. -

      PEACE Registry: 12-month results Michael Lichtenberg

        Michael Lichtenberg
    6. -

      Live case transmission from Palermo

    7. -

      Personal Experiences with Passeo-18 Lux DRB

        Paul Myers
    8. -

      Take-home message

Cookie settings

We use cookies so that we can offer you the best possible website experience. This includes cookies which are necessary for the operation of the website and to manage our corporate commercial objectives, as well as other cookies which are used solely for anonymous statistical purposes, for more comfortable website settings, or for the display of personalised content. You are free to decide which categories you would like to permit. Please note that depending on the settings you choose, the full functionality of the website may no longer be available. Further information can be found in our privacy statement and legal notice.

  • We are using cookies in order to enable the services of the website and to ensure that certain aspects work as required. The cookies within this group are essential for the correct appearance and functionality of the website. No information within these cookies will be given to third parties.

  • We're using functional tracking to analyze the usage of our website. The data hereby gathered, allows us to find errors and improve designs. It also enables us to test the efficacy of our website. These cookies furthermore help us in analyzing our advertisements and affiliate marketing.

  • Our website makes use of external services such as Issuu. These services provide great value to us and to you as a user. However they do write cookies and collect data about their usage on this website. In order for you to be able to use these services, you will have to give your consent to their respective cookies.